VisionClearBlue Eye Clinic Business Plan — Financial Plan

This section and the four that follow present a complete, internally consistent financial model. The sponsor brief provides targets, Year-5 revenue exceeding R1.2 billion, an EBITDA margin of 20 to 25%, a R450 million capital programme for nine clinics, and operational volumes of ~180,000 consultations, ~20,000 surgeries and ~100,000 optical sales a year. This model builds a transparent, year-by-year financial plan consistent with those targets: it derives revenue from an explicit clinic-by-clinic rollout and maturation, applies a margin that ramps into the target band, and independently derives every line below EBITDA, the equipment-heavy depreciation, full cash interest on drawn debt, and 27% tax with assessed-loss carry-forward. The balance sheet is constructed to tie in every year, and the cash flow reconciles to the movement in cash.

Key performance indicators to monitor

Lenders and equity investors will track a defined set of indicators through the rollout. The dashboard below sets out the metrics, their purpose, and the modelled trajectory, the same measures against which drawdowns, covenants and board reporting should be structured.

Indicator	What it signals	Modelled trajectory
Clinics open & network maturity	Rollout & ramp progress	3 → 9 clinics; 13% → 100% mature
Ophthalmologists recruited	The binding constraint	Toward 18, metros first
Surgeries per year	Throughput vs target	~2,700 → 20,000
EBITDA margin	Operating leverage	–5% → 22% (into target band)
DSCR	Debt serviceability	Negative in Year 1 — grace period required
Cash balance	Liquidity through the build	Positive; thins to ~R77m in Year 3
Medical-aid receivable days	Cash conversion	Managed via central revenue cycle
Net debt / EBITDA	Leverage	Not meaningful early; net cash by Year 5

Financial performance at a glance

The dashboard below summarises the model’s headline outputs across the five-year projection: a capital-intensive, cash-consumptive rollout giving way to strong profitability and rapid margin expansion as the nine clinics open and mature toward the sponsor’s Year-5 targets.

Metric	Year 1	Year 3	Year 5
Revenue (R m)	162	859	1,215
EBITDA (R m)	-8	129	267
EBITDA margin	-5.0%	15.0%	22.0%
Net profit (R m)	-32	51	136
Clinics open	3	9	9
Surgeries	2,667	14,140	20,000
DSCR (x)	-1.54x	7.08x	2.77x
ROCE	-5.9%	11.5%	24.2%

Revenue by service line at maturity

The revenue base is diversified across five service lines, so that high-value surgery is balanced by steadier consultation and optical revenue. The breakdown below applies the target service mix to the Year-5 revenue of R1,215m.

Service line	Share	Year-5 revenue (R m)
Surgical services (cataract, laser, retina, glaucoma)	48%	583
Consultations & diagnostics	22%	267
Optical retail & contact lenses	21%	255
Corporate, occupational & screening	6%	73
Telemedicine & government	3%	36
Total	100%	1,215

Figure 18. *Revenue mix at maturity by service line*

Key modelling assumptions

Assumption	Value	Basis
Clinics	9 flagship (one per province)	Phased 3 / 3 / 3 over Years 1–3
Mature revenue per clinic	~R135m/year	High-throughput flagship run-rate
Clinic ramp	~40% / 72% / 100% by age	~3-year maturation per clinic
Year-5 EBITDA margin	~22%	Within the 20–25% target band
Depreciation	Straight-line by component	Equipment 4–10 yr; from commissioning
Funding mix	Equity R280m / Debt R170m	~38% gearing
Cost of debt	11.5%	~ prime + 100bps (healthcare)
Working capital	~9% of revenue	Medical-aid receivables net of payables
Corporate tax	27%	With 80% assessed-loss set-off cap
Exit multiple	8.5x EV/EBITDA	Specialist healthcare-services comparable

Sources and uses

Uses of funds (9 clinics)	R m	Sources of funds	R m
Medical equipment	162	Equity investment	280
Laser systems	108	Development / equipment debt	170
Theatre equipment	54
Optical laboratories	27
Furniture & fit-out	45
IT systems	18
Working capital	36
Total uses	450	Total sources	450

Figure 19. *Funding structure at financial close*

NoteThe R450m funds the build — a working-capital facility must sit alongside it

The R450 million programme equips nine clinics and seeds each with R4 million of working capital. But a healthcare rollout also absorbs cash through early operating losses and a growing medical-aid receivable book as clinics ramp. The model holds cash positive across the rollout, with the trough at about R77 million in Year 3 when all nine clinics are built but the later ones are still loss-making. Prudence demands a committed working-capital facility for medical-aid receivables and a standby facility on top of the R450 million, the headline figure funds the build, not the full peak funding need through the ramp.

Alignment with impact and development-finance mandates

The transaction is structured for a blend of equity, development finance and impact-health capital, and its features map directly onto their mandates. VisionClearBlue delivers accessible specialist eye care in under-served provinces, reduces avoidable blindness, screens at scale for diabetic retinopathy, and creates over 300 skilled healthcare jobs, core health-system objectives for development-finance institutions and impact investors. For commercial lenders, the equipped clinics provide tangible, collateral-grade security and medical-aid receivables represent claims on regulated schemes. The health-impact case and the financial case reinforce one another, which is what makes the plan financeable to mandate-driven capital even before the exceptional headline returns.

Healthcare peer economics — a reality check

South African private-healthcare operators discipline the plan’s assumptions. The listed hospital groups (Netcare, Life Healthcare, Mediclinic) and day-surgery operators demonstrate that specialist-healthcare economics are attractive but capital-intensive and regulated, and that private eye care sits within a fragmented specialist landscape. VisionClearBlue’s integrated, eye-only, national model is differentiated from all of them, but it inherits the sector’s central lesson: clinical capacity, not capital, is the constraint. The table frames the comparison.

Dimension	Hospital groups	Optical chains	VisionClearBlue
Model	Multi-specialty hospitals	Retail spectacles	Integrated eye-only network
Eye care	Ophthalmology units	Optometry / dispensing	Full continuum incl. surgery
Constraint	Beds, specialists, tariffs	Footfall, margin	Ophthalmologist supply
Relevance	Tariff & regulatory read	Optical benchmark	First integrated national play